Maternal folic acid supplementation and the risk of congenital heart defects in offspring: A meta-analysis of epidemiological observational studies

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Feng, Yu ^a   Wang, Song ^a   Chen, Runsen ^a   Tong, Xing ^b   Wu, Zeyu ^a   Mo, Xuming ^a  

^a CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

DIET SUPPLEMENTATION; ENVIRONMENTAL EXPOSURE; FEMALE; HEART DEFECTS, CONGENITAL; HUMAN; META ANALYSIS; ODDS RATIO; PREGNANCY; PRENATAL EXPOSURE; RISK;

DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HEART DEFECTS, CONGENITAL; HUMANS; MATERNAL EXPOSURE; ODDS RATIO; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK;

EID: 84923367041     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08506     Document Type: Article

References (43)

1. Pierpont, M. E. et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115, 3015-3038 (2007).
2. Boneva, R. S. et al. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 103, 2376-2381 (2001).
3. Brent, R. L. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics 113, 957-968 (2004).
4. Jenkins, K. J. et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115, 2995-3014 (2007).
5. Smithells, R. W. & Sheppard, S. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1, 647 (1980).
6. Laurence, K. M., James, N., Miller, M. H., Tennant, G. B. & Campbell, H. Doubleblind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 282, 1509-1511 (1981).
7. Food labeling: health claims and labeling statements; dietary fiber and cancer; antioxidant vitamins and cancer; omega-3 fatty acids and coronary heart disease; folate and neural tube defects; revocation. Food and Drug Administration, HHS. Final rule. Fed Regist 65, 58917-58918 (2000).
8. Czeizel, A. E. Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 78, 151-161 (1998).
9. Czeizel, A. E., Dobo, M. & Vargha, P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol 70, 853-861 (2004).
10. Bean, L. J. et al. Lack of maternal folic acid supplementation is associated with heart defects in Down syndrome: a report from the National Down Syndrome Project. Birth Defects Res A Clin Mol Teratol 91, 885-893 (2011).
11. Botto, L. D., Mulinare, J. & Erickson, J. D. Occurrence of congenital heart defects in relation to maternal mulitivitamin use. Am J Epidemiol 151, 878-884 (2000).
12. Correa, A., Botto, L., Liu, Y., Mulinare, J. & Erickson, J. D. Do multivitamin supplements attenuate the risk for diabetes-associated birth defects? Pediatrics 111, 1146-1151 (2003).
13. Csaky-Szunyogh, M., Vereczkey, A., Kosa, Z., Gerencser, B. & Czeizel, A. E. Risk and protective factors in the origin of conotruncal defects of heart-a populationbased case-control study. Am J Med Genet A 161A, 2444-2452 (2013).
14. Csaky-Szunyogh, M., Vereczkey, A., Kosa, Z., Urban, R. & Czeizel, A. E. Association of maternal diseases during pregnancy with the risk of single ventricular septal defects in the offspring-a population-based case-control study. J Matern Fetal Neonatal Med 26, 738-747 (2013).
15. Csaky-Szunyogh, M., Vereczkey, A., Kosa, Z., Gerencser, B. & Czeizel, A. E. Risk factors in the origin of congenital left-ventricular outflow-tract obstruction defects of the heart: a population-based case-control study. Pediatc cardiol 35, 108-120 (2014).
16. Hobbs, C. A., MacLeod, S. L., Jill James, S. & Cleves, M. A. Congenital heart defects and maternal genetic, metabolic, and lifestyle factors. Birth Defects Res A Clin Mol Teratol 91, 195-203 (2011).
17. Li, X. et al. The association between periconceptional folic acid supplementation and congenital heart defects: a case-control study in China. Prev Med 56, 385-389 (2013).
18. Malik, S. et al. Maternal smoking and congenital heart defects. Pediatrics 121, e810-816 (2008).
19. Obermann-Borst, S. A. et al. General maternal medication use, folic acid, the MDR1 C3435T polymorphism, and the risk of a child with a congenital heart defect. Am J Obstet Gynecol 204 (2011).
20. Scanlon, K. S. et al. Preconceptional folate intake and malformations of the cardiac outflow tract. Baltimore-Washington Infant Study Group. Epidemiology 9, 95-98 (1998).
21. Shaw, G.M., O'Malley, C. D., Wasserman, C. R., Tolarova, M. M. & Lammer, E. J. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am JMed Genet 59, 536-545 (1995).
22. van Beynum, I. M. et al. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur Heart J 31, 464-471 (2010).
23. Vereczkey, A., Kosa, Z., Csaky-Szunyogh, M. & Czeizel, A. E. Isolated atrioventricular canal defects: birth outcomes and risk factors: a population-based Hungarian case-control study, 1980-1996. Birth Defects Res AClin Mol Teratol 97, 217-224 (2013).
24. Werler, M. M., Hayes, C., Louik, C., Shapiro, S. & Mitchell, A. A. Multivitamin supplementation and risk of birth defects. Am J Epidemiol 150, 675-682 (1999).
25. Williams, L. J., Correa, A. & Rasmussen, S. Maternal lifestyle factors and risk for ventricular septal defects. Birth Defects Res A Clin Mol Teratol 70, 59-64 (2004).
26. Jacques, P. F., Bostom, A. G., Williams, R. R., Ellison, R. C. & Eckfeldt, J. H. Relation between folate status, a commonmutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 7-9 (1996).
27. Kapusta, L., Haagmans, M. L., Steegers, E. A., Cuypers, M. H. & Blom, H. J. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 135, 773-774 (1999).
28. Hobbs, C., Cleves, M. A., Melnyk, S., Zhao, W. & James, J. S. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr 81, 147-153 (2005).
29. Hernandez-Diaz, S., Werler, M. M., Walker, A. M. & Mitchell, A. A. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343, 1608-1614 (2000).
30. Boot, M. J. et al. Folic acid and homocysteine affect neural crest and neuroepithelial cell outgrowth and differentiation in vitro. Dev Dyn 227, 301-308 (2003).
31. Tierney, B. J., Ho, T., Reedy, M. V. & Brauer, P. R. Homocysteine inhibits cardiac neural crest cell formation and morphogenesis in vivo. Dev Dyn 229, 63-73 (2004).
32. Tang, L. S., Wlodarczyk, B. J., Santillano, D. R., Miranda, R. C. & Finnell, R. H. Developmental consequences of abnormal folate transport during murine heart morphogenesis. Birth Defects Res A Clin Mol Teratol 70, 449-458 (2004).
33. van Beynum, I.M. et al. Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 27, 981-987 (2006).
34. Wild, J., Sutcliffe, M., Schorah, C. J. & Levene, M. I. Prevention of neural-tube defects. Lancet 350, 30-31 (1997).
35. Holmes, L., Harris, J., Oakley, G. P., Jr. & Friedman, J. M. Teratology Society Consensus Statement on use of folic acid to reduce the risk of birth defects. Teratology 55, 381 (1997).
36. Ray, J. G., Wyatt, P. R., Vermeulen, M. J., Meier, C. & Cole, D. E. Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Obstet Gynecol 105, 261-265 (2005).
37. Mojtabai, R. Body mass index and serum folate in childbearing age women. Eur J Epidemiol 19, 1029-1036 (2004).
38. Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama 283, 2008-2012 (2000).
39. Wells, G. A. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses.comparison. Available from: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed Ma 3, 2013. (2013).
40. Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. Bmj 327, 557-560 (2003).
41. Woolf, B. On estimating the relation between blood group and disease. Ann Hum Genet 19, 251-253 (1955).
42. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. Bmj 315, 629-634 (1997).
43. Begg, C. B. & Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-1101 (1994).